Početna › Amiloidoza › Texas
Kliničke studije za Amiloidoza u državi Texas
11 studija za Amiloidoza traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
Službeni tekst studije (engleski)
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
- MD Anderson Cancer Center, Houston
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT05652335Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Dallas
- Research Site, Houston
U tijeku regrutacijaOpažajna studija
Od 18 do 130 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Austin
- Clinical Trial Site, Dallas
- Clinical Trial Site, Houston
- i još 1
U tijeku regrutacijaFaza 3
Od 18 do 85 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Clinical Trial Site, Dallas
- Clinical Trial Site, Houston
U tijeku regrutacijaFaza 3
Od 18 do 85 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07223203DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, Dallas
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07358078ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, Austin
- Clinical Trial Site, Houston
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 8. ruj 2026. · NCT04561518Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
- University of Texas Southwestern Medical Center, Dallas
U tijeku regrutacijaOpažajna studija
Od 30 do 80 godina · Oba spola · Ažurirano 31. kol 2026. · NCT05489549Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
- UT Southwestern Medical Center, Dallas
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 19. kol 2026. · NCT05145816Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- National Neuromuscular Research Institute, Austin
- University of Texas Southwestern, Dallas
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 4. kol 2026. · NCT06563895MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern Medical Center, Dallas
- Baylor College of Medicine, Houston
- i još 2
U tijeku regrutacijaFaza 3
Od 18 do 90 godina · Oba spola · Ažurirano 27. ožu 2026. · NCT06128629Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study
- UT Southwestern Medical Center, Dallas
U tijeku regrutacijaOpažajna studija
Od 30 do 80 godina · Oba spola · Ažurirano 7. sij 2026. · NCT07196839Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.